Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
Clinical trial NCT03529526 · UNKNOWN
Trial details
- NCT number
- NCT03529526
- Sponsor
- Alphamab (Australia) Co Pty Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2019-10-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.